Welcome to the September 2022 edition of the HealthTech Activator (HTA) Monthly Wrap. The beginning of this month saw the launch of the 2022 TIN Healthtech Insights Report: healthtech is a $2.9B sector, and its eleven TIN200 companies (5.5%) accounted for just over 20% of overall TIN200 revenue and 51.2% of growth.
This month’s HTA blog features Peter Townsend CNZM discussing the importance of continuing to support innovation across the sector and the specific role played by Te Papa Hauora, Christchurch Health Precinct in Canterbury.
The HTA has several upcoming events with a couple of company spots still available, so get in quick if you’re interested! On October 20th, we’ll be hosting companies in Auckland for the next Knowing your Customer and your Market workshop, and on November 3rd we’ll be in Christchurch for a valuation workshop. You can view all upcoming events on the HTA website.
Read on for links to everything mentioned above and more sector news from the past month.
If you have any comments or suggestions to improve this newsletter, we would love to hear from you! As always, thanks for subscribing to the HTA.
HTA news
Innovation - key to a successful health system
Peter Townsend CNZM, Independent Chair of Te Papa Hauora Advisory Council, Christchurch Health Precinct
In this month’s HTA blog, Peter Townsend CNZM discusses the importance of innovation in health and the role played by Te Papa Hauora, Christchurch Health Precinct in Canterbury.
20 October, Auckland | Facilitated by Dan Hansen and Will Perry of Apagie This popular in-person workshop is part of the HTA market validation series and is aimed at healthtech companies taking a fresh look at their market and the way they validate it.
Leveraging their wealth of cross-industry experience, Apagie’s Dan Hansen and Will Perry walk you through the right processes and perspectives for successfully commercialising your health technology.
3 November, Christchurch | Facilitated by Jai Basrur of CGB Consulting Our next HTA Christchurch valuation workshop is ideal for healthtech business founders wanting to improve their understanding of company valuations and the role they play in capital raising.
Run by Jai Basrur from CGB Consulting, this in-person workshop provides an overview of the principles and techniques involved in valuing a company - including hands-on exercises using valuation methods.
From biochemical engineer to RespirAq CEO (paywall) NBR profiles Sandra Grau-Bartual, CEO of RespirAq. In late 2021 RespirAq raised $1.5m to accelerate commercialisation of their humidifier innovation (5 September: NBR)
Kiwi startup raising $6m for breakthrough implantable medtech Watch Kitea Health’s Natalia Lopez pitch their pressure sensor technology at the Icehouse Ventures Showcase - Kitea Health are seeking $6m in funding for first-in-human trials (19 September: NZ Herald)
